Raymond James Financial Services Advisors Inc. Trims Stake in Forian Inc. (NASDAQ:FORA)

Raymond James Financial Services Advisors Inc. reduced its position in Forian Inc. (NASDAQ:FORA) by 31.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 27,478 shares of the company’s stock after selling 12,522 shares during the period. Raymond James Financial Services Advisors Inc. owned 0.09% of Forian worth $80,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in FORA. Independent Advisor Alliance raised its stake in Forian by 21.2% during the 3rd quarter. Independent Advisor Alliance now owns 22,491 shares of the company’s stock valued at $50,000 after acquiring an additional 3,936 shares during the last quarter. Pathstone Family Office LLC purchased a new stake in Forian during the 3rd quarter valued at approximately $39,000. Aufman Associates Inc purchased a new stake in Forian during the 3rd quarter valued at approximately $117,000. Finally, Oracle Investment Management Inc. raised its stake in Forian by 0.3% during the 3rd quarter. Oracle Investment Management Inc. now owns 1,368,067 shares of the company’s stock valued at $3,051,000 after acquiring an additional 3,738 shares during the last quarter. 19.25% of the stock is owned by hedge funds and other institutional investors.

Forian Trading Up 4.6 %

NASDAQ FORA opened at $2.72 on Friday. The business’s 50 day moving average is $2.97 and its two-hundred day moving average is $2.75. Forian Inc. has a 12-month low of $1.85 and a 12-month high of $4.15. The stock has a market capitalization of $84.68 million, a price-to-earnings ratio of 8.24 and a beta of 1.03.

Forian (NASDAQ:FORA) last released its earnings results on Thursday, March 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $5.37 million during the quarter, compared to the consensus estimate of $5.72 million.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reaffirmed a “buy” rating and set a $5.00 price objective on shares of Forian in a research note on Thursday, April 4th.

Forian Company Profile

Forian Inc provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other.